ATE401303T1 - Verfahren zur herstellung von ed-71 - Google Patents
Verfahren zur herstellung von ed-71Info
- Publication number
- ATE401303T1 ATE401303T1 AT99905280T AT99905280T ATE401303T1 AT E401303 T1 ATE401303 T1 AT E401303T1 AT 99905280 T AT99905280 T AT 99905280T AT 99905280 T AT99905280 T AT 99905280T AT E401303 T1 ATE401303 T1 AT E401303T1
- Authority
- AT
- Austria
- Prior art keywords
- vitamin
- derivatives
- protective group
- represents hydrogen
- producing
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/44—Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4229598 | 1998-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401303T1 true ATE401303T1 (de) | 2008-08-15 |
Family
ID=12632059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99905280T ATE401303T1 (de) | 1998-02-24 | 1999-02-23 | Verfahren zur herstellung von ed-71 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1061070B1 (de) |
| JP (2) | JP4357114B2 (de) |
| AT (1) | ATE401303T1 (de) |
| AU (1) | AU2549099A (de) |
| DE (1) | DE69939106D1 (de) |
| WO (1) | WO1999043645A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6335458B1 (en) * | 1998-02-27 | 2002-01-01 | Chugai Seiyaku Kabushiki Kaisha | Intermediate compounds in the synthesis of the A ring moiety of 2-substituted vitamin D derivatives |
| CA2586679A1 (en) | 2004-11-12 | 2006-05-18 | Bioxell Spa | Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| EP2093193B1 (de) | 2006-11-22 | 2012-04-25 | Shiseido Company, Limited | Verfahren zur herstellung von feinteiligem zinkoxidpulver |
| MX312760B (es) | 2008-07-18 | 2013-08-29 | Basf Se | Particulas de oxido de zinc modificado. |
| CN103180293B (zh) * | 2010-10-25 | 2015-06-17 | 帝人制药株式会社 | 23-炔-维生素d3衍生物 |
| WO2013162047A1 (ja) * | 2012-04-24 | 2013-10-31 | 帝人ファーマ株式会社 | 二次性副甲状腺機能亢進症治療剤 |
| PT3969459T (pt) | 2019-05-13 | 2023-11-20 | Faes Farma Sa | Processo e intermediários para a preparação de eldecalcitol |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51108048A (en) * | 1975-03-17 | 1976-09-25 | Teijin Ltd | 1 arufua * 24 * s * *255 torihidokishikorekarushifuerooruno seizoho |
| JPS5846507B2 (ja) * | 1978-12-26 | 1983-10-17 | 帝人株式会社 | 1α,24(R),25↓−トリヒドロキシコレカルシフエロ−ルの製造法 |
| JPS58208223A (ja) * | 1982-05-28 | 1983-12-03 | Kureha Chem Ind Co Ltd | 抗腫瘍剤 |
| US4666634A (en) * | 1984-12-05 | 1987-05-19 | Chugai Seiyaku Kabushiki Kaisha | vitamin D3 derivatives having a substituent at 2-position |
| JPH0780773B2 (ja) * | 1986-06-05 | 1995-08-30 | 中外製薬株式会社 | 新規ビタミンd▲下3▼誘導体を有効成分とする医薬 |
| PT972762E (pt) * | 1993-07-09 | 2004-02-27 | Theramex | Novos analogos estruturais da vitamina d |
| JP3712077B2 (ja) * | 1995-05-12 | 2005-11-02 | 株式会社クラレ | ヒドロインダン−4−オール誘導体およびその製造方法 |
| JPH11130711A (ja) * | 1997-10-24 | 1999-05-18 | Teijin Ltd | 1α,24,25−トリヒドロキシビタミンD3類の合成中間体およびその製造法 |
| US6335458B1 (en) * | 1998-02-27 | 2002-01-01 | Chugai Seiyaku Kabushiki Kaisha | Intermediate compounds in the synthesis of the A ring moiety of 2-substituted vitamin D derivatives |
-
1999
- 1999-02-23 JP JP2000533404A patent/JP4357114B2/ja not_active Expired - Fee Related
- 1999-02-23 EP EP99905280A patent/EP1061070B1/de not_active Expired - Lifetime
- 1999-02-23 DE DE69939106T patent/DE69939106D1/de not_active Expired - Lifetime
- 1999-02-23 WO PCT/JP1999/000796 patent/WO1999043645A1/ja not_active Ceased
- 1999-02-23 AU AU25490/99A patent/AU2549099A/en not_active Abandoned
- 1999-02-23 AT AT99905280T patent/ATE401303T1/de not_active IP Right Cessation
-
2009
- 2009-06-23 JP JP2009148244A patent/JP4990937B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4357114B2 (ja) | 2009-11-04 |
| DE69939106D1 (de) | 2008-08-28 |
| EP1061070A1 (de) | 2000-12-20 |
| EP1061070A4 (de) | 2005-03-30 |
| WO1999043645A1 (en) | 1999-09-02 |
| EP1061070B1 (de) | 2008-07-16 |
| JP4990937B2 (ja) | 2012-08-01 |
| AU2549099A (en) | 1999-09-15 |
| JP2009256361A (ja) | 2009-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE267822T1 (de) | Verfahren zur herstellung von luteolin und luteolin-derivaten | |
| GB2331015A (en) | Therapeutic methods and compositions involving isoflavones | |
| DE69325262D1 (de) | Vinylen-azaindolderivate und verfahren zu ihrer herstellung | |
| ATE129503T1 (de) | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien. | |
| DE69113155D1 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung. | |
| ATE246196T1 (de) | Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon | |
| ATE234304T1 (de) | Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte | |
| DE69838146D1 (de) | Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben | |
| MY145819A (en) | Process and intermediates useful in the preparation of pharmaceutical compounds as fulvestrant | |
| ATE211474T1 (de) | Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente | |
| ATE134623T1 (de) | Salicyl(thio)etherderivate, verfahren und zwischenprodukte zu ihrer herstellung | |
| ATE401303T1 (de) | Verfahren zur herstellung von ed-71 | |
| DE60235365D1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
| MX9708735A (es) | Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos. | |
| ATE292962T1 (de) | Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur vorbeugung und behandlung von parodontitis | |
| ATE229006T1 (de) | Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte | |
| NZ324775A (en) | 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof | |
| DE60224884D1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
| AU639154B2 (en) | New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them | |
| ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| AR001767A1 (es) | Derivados de ciclolignanos utiles como inmunosupresores composiciones farmaceuticas que los contienen y procedimiento para preparar dichos derivados | |
| ATE299851T1 (de) | Verfahren zur herstellung von zwischenprodukten | |
| ATE189887T1 (de) | Vitamin-d-derivat und verfahren zu seiner herstellung | |
| DK0521766T3 (da) | Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |